2018 - Fellow of the Royal Society of Canada Academy of Science
2016 - Benjamin Franklin Medal, Franklin Institute
2014 - Breakthrough Prize in Life Sciences for discoveries leading to the development of controlled drug-release systems and new biomaterials.
2013 - Fellow of the American Association for the Advancement of Science (AAAS)
2013 - IEEE Medal for Innovations in Healthcare Technology “For pioneering and innovative therapies using micro- and nanoengineering approaches and biomaterials to tissue engineering, drug delivery, and cancer therapeutics.”
2013 - Wolf Prize in Chemistry, Wolf Foundation for conceiving and implementing advances in polymer chemistry that provide both controlled drug-release systems and new biomaterials.
2012 - Fellow, National Academy of Inventors
2012 - Perkin Medal, Society of Chemical Industry, American Section
2012 - Priestley Medal, American Chemical Society (ACS)
2011 - Fellow of the American Chemical Society
2011 - Warren Alpert Foundation Prize In recognition of their extraordinary contributions to medicine and innovations in bioengineering.
2010 - Fellow of the Royal Academy of Engineering (UK)
2009 - Fellow of the Materials Research Society
2008 - Max Planck Research Award Biomaterials
2006 - US President's National Medal of Science "For his revolutionary discoveries in the areas of polymeric controlled release systems and tissue engineering and synthesis of new materials that have led to new medical treatments that have profoundly affected the well being of mankind.", Awarded by President George W. Bush in a White House ceremony on July 27, 2007.
2005 - Albany Medical Center Prize in Medicine and Biomedical Research
2005 - Von Hippel Award, Materials Research Society
1996 - Canada Gairdner International Award
1996 - Fellow of Biomaterials Science and Engineering
1994 - Fellow of the American Academy of Arts and Sciences
1992 - Fellow of the Indian National Academy of Engineering (INAE)
1992 - Member of the National Academy of Engineering For innovative research in chemical aspects of biomedical engineering, particularly in the field of controlled release of macromolecules and proteins.
1992 - Member of the National Academy of Sciences
1989 - Member of the National Academy of Medicine (NAM)
His primary areas of study are Nanotechnology, Drug delivery, Tissue engineering, Polymer and Biomedical engineering. In general Nanotechnology, his work in Nanoparticle, Nanomedicine and Microfluidics is often linked to Extramural linking many areas of study. His Drug delivery research is multidisciplinary, incorporating perspectives in Drug and Transdermal.
His Tissue engineering research is multidisciplinary, relying on both Cell culture, Biomaterial, Biophysics, Anatomy and Transplantation. His study in Polymer is interdisciplinary in nature, drawing from both Biodegradation, Chemical engineering and Polymer chemistry. His work in Biomedical engineering addresses subjects such as In vivo, which are connected to disciplines such as Pharmacology.
Robert Langer mostly deals with Nanotechnology, Polymer, Biomedical engineering, Drug delivery and In vivo. His work is connected to Nanoparticle and Microfluidics, as a part of Nanotechnology. The Polymer study combines topics in areas such as Chemical engineering, Controlled release and Polymer chemistry.
A large part of his Biomedical engineering studies is devoted to Tissue engineering. Many of his studies on Drug delivery apply to Pharmacology as well. His studies link In vitro with In vivo.
The scientist’s investigation covers issues in Drug delivery, Biomedical engineering, In vivo, Pharmacology and Nanotechnology. His Drug delivery study frequently links to adjacent areas such as Controlled release. He combines subjects such as Biophysics, Cancer research and Messenger RNA with his study of In vivo.
His Cancer research research incorporates themes from Cancer and Metastasis. Robert Langer mostly deals with Drug in his studies of Pharmacology. His Nanotechnology study combines topics in areas such as Self-healing hydrogels and Polymer.
His primary scientific interests are in Drug delivery, In vivo, Nanotechnology, Pharmacology and Immunology. His research integrates issues of Biomolecule and Inflammatory bowel disease in his study of Drug delivery. His study focuses on the intersection of In vivo and fields such as Molecular biology with connections in the field of Transfection.
Robert Langer focuses mostly in the field of Nanotechnology, narrowing it down to topics relating to Polymer and, in certain cases, Polymer chemistry. While the research belongs to areas of Pharmacology, he spends his time largely on the problem of Diabetes mellitus, intersecting his research to questions surrounding Transplantation. The various areas that Robert Langer examines in his Drug study include Dosage form and Controlled release.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nanocarriers as an emerging platform for cancer therapy
Dan Peer;Jeffrey M. Karp;Jeffrey M. Karp;Seungpyo Hong;Omid C. Farokhzad.
Nature Nanotechnology (2007)
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology†
Nicholas A. Peppas;J. Zach Hilt;Ali Khademhosseini;Ali Khademhosseini;Robert Langer.
Advanced Materials (2006)
Designing materials for biology and medicine
Robert Langer;David A. Tirrell.
Biodegradable long-circulating polymeric nanospheres
Ruxandra Gref;Yoshiharu Minamitake;Maria Teresa Peracchia;Vladimir Trubetskoy.
Polymeric Systems for Controlled Drug Release
Kathryn E. Uhrich;Scott M. Cannizzaro;Robert S. Langer;Kevin M. Shakesheff.
Chemical Reviews (1999)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead;Robert Langer;Daniel G. Anderson.
Nature Reviews Drug Discovery (2009)
Drug delivery and targeting
Shape memory polymers
Robert S. Langer;Andreas Lendlein.
Angewandte Chemie (2002)
New methods of drug delivery.
Impact of Nanotechnology on Drug Delivery
Omid C Farokhzad;Robert D. Langer.
ACS Nano (2009)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: